XOS and Aljomaih limit share issuance to 19.99% under convertible note
Rhea-AI Filing Summary
Xos, Inc. and Aljomaih amended terms of a convertible note to limit share-based interest and conversion dilution. The parties agreed a cap of 1,737,247 common shares (about 19.99% of outstanding stock as of August 8, 2025) that may be delivered as interest shares or issued on conversion, subject to adjustment.
If interest or conversion obligations would exceed that cap, excess interest will be paid in cash within five business days after the earlier of August 11, 2026 or the date shareholder approval is obtained to exceed the cap. The amendment clarifies conversion/interest-share mechanics and limits share issuance in the near term.
Positive
- Cap on dilution: The amendment limits total Interest Shares and conversion-related issuances to 1,737,247 shares (19.99%), reducing immediate dilution risk.
- Cash alternative: Any interest amounts exceeding the cap must be paid in cash by the earlier of August 11, 2026 or shareholder approval to exceed the cap, preventing automatic share issuance beyond the Limit.
- Transparency and mechanics clarified: The Letter clarifies how Interest Shares and conversion issuances are treated, improving predictability for shareholders and modelers.
Negative
- None.
Insights
TL;DR: Amendment caps share-based dilution from the convertible note at 19.99%, creating a near-term limit on equity issuance tied to interest and conversion.
The Letter formalizes a quantitative ceiling of 1,737,247 shares for Interest Shares and conversion-related issuance, which constrains dilution that could arise from the Convertible Note. By requiring cash payment for any interest beyond the cap until either shareholder approval or August 11, 2026, the company preserves flexibility to avoid immediate excessive share issuance but assumes additional near-term cash obligations if the cap is reached. For financial modeling, treat potential dilution as limited to the stated cap pending any shareholder vote or adjustment.
TL;DR: The amendment protects existing shareholders by imposing a clear limit on equity issuance tied to the note and specifying alternative cash payments.
The agreement sets an explicit, adjustable Limit equal to approximately 19.99% of outstanding common stock as of August 8, 2025, and clarifies issuance mechanics for Interest Shares. This provides transparency on potential dilution and ties any increase above the Limit to a shareholder approval process or a deferred cash-payment timeline. From a governance perspective, codifying shareholder approval as a condition to exceed the cap strengthens shareholder control over dilution decisions.
FAQ
What limit does the XOS and Aljomaih amendment place on share issuance?
What happens if interest or conversion obligations exceed the 1,737,247-share cap?
Does the amendment change conversion mechanics for the Convertible Note?
Is shareholder approval required to exceed the cap?
When does the cash-payment alternative deadline occur if the cap is exceeded?